Trial Profile
A Phase II Study of ORZEL (UFT + Leucovorin) in Elderly (at Least 75 Years Old) Patients With Colorectal Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Jun 2023
Price :
$35
*
At a glance
- Drugs Tegafur/uracil (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 11 Jan 2007 Status changed from in progress to completed
- 23 Sep 2005 New trial record.